6. The Link Between SCN and Cancer Risks
SCN patients face an elevated risk of developing certain cancers. These include acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
The risk arises from the genetic mutations that cause SCN. It’s a significant concern in the long-term management of the disorder.
Regular monitoring for signs of cancer is crucial for SCN patients. This involves periodic blood tests and medical evaluations. Early detection of cancer can significantly improve treatment outcomes. It’s a vital part of the care plan for SCN patients.
Researchers are actively studying ways to reduce the cancer risk in SCN. This includes investigating the effects of different treatments. Understanding the mechanisms that lead to cancer in SCN is key. It could lead to more effective prevention strategies.
The increased cancer risk can be a source of anxiety for SCN patients and their families. Counseling and support services are essential. They provide much-needed emotional and psychological support. They also help in coping with this aspect of the disorder. (6)
